Entities / Company
Nuvalent, Inc. (United States).
company in Cambridge, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 20
What's happening
Gone quiet
No new reports in 90+ days-
Nuvalent, Inc.'s New Drug Application (NDA) was accepted by the FDA for Priority Review.Some support4 reports
-
Positive trial data led H.C. Wainwright to raise the price target for Nuvalent, Inc. on June 25, 2025.Some support2 reports
-
Nuvalent, Inc. reported results from its operations in Cambridge, Massachusetts on August 7, 2025.Some support2 reports
-
Christopher Turner was appointed Chief Medical Officer of Nuvalent, Inc. on August 14, 2025.Some support1 report
-
James Porter was appointed CEO of Nuvalent, Inc. on August 28, 2025.Some support1 report
-
Piper Sandler initiated coverage of Nuvalent, Inc. on September 2, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Nuvalent, Inc. (United States) this week
News at the entities that move Nuvalent, Inc. (United States) most-
Cambridge Shared contextA book featuring Alice Hoffman is set in Cambridge during the 1950s.Moves Nuvalent, Inc. (United States)
Connections
The 2 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
James Porter Structural
James Porter serves as the Chief Executive Officer of Nuvalent, Inc.
-
Cambridge Shared context
Nuvalent, Inc. is consistently reported as being based and operating in Cambridge, Massachusetts.
History
Events by the month they beganJune 2026
6 events- Nuvalent, Inc.'s New Drug Application (NDA) was accepted by the FDA for Priority Review.
- Positive trial data led H.C. Wainwright to raise the price target for Nuvalent, Inc. on June 25, 2025.
- Nuvalent, Inc. reported results from its operations in Cambridge, Massachusetts on August 7, 2025.
- Christopher Turner was appointed Chief Medical Officer of Nuvalent, Inc. on August 14, 2025.
- James Porter was appointed CEO of Nuvalent, Inc. on August 28, 2025.
- Piper Sandler initiated coverage of Nuvalent, Inc. on September 2, 2025.